These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8649796)

  • 1. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
    Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
    Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
    Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
    Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
    Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
    Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells.
    Dewson G; Snowden RT; Almond JB; Dyer MJ; Cohen GM
    Oncogene; 2003 May; 22(17):2643-54. PubMed ID: 12730678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells.
    Sanz L; Garcia-Marco JA; Casanova B; de La Fuente MT; García-Gila M; Garcia-Pardo A; Silva A
    Biochem Biophys Res Commun; 2004 Mar; 315(3):562-7. PubMed ID: 14975737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance.
    Bannerji R; Kitada S; Flinn IW; Pearson M; Young D; Reed JC; Byrd JC
    J Clin Oncol; 2003 Apr; 21(8):1466-71. PubMed ID: 12697868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX.
    McConkey DJ; Chandra J; Wright S; Plunkett W; McDonnell TJ; Reed JC; Keating M
    J Immunol; 1996 Apr; 156(7):2624-30. PubMed ID: 8786328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
    Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT
    Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways.
    Selvakumaran M; Lin HK; Miyashita T; Wang HG; Krajewski S; Reed JC; Hoffman B; Liebermann D
    Oncogene; 1994 Jun; 9(6):1791-8. PubMed ID: 8183578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia.
    Saxena A; Viswanathan S; Moshynska O; Tandon P; Sankaran K; Sheridan DP
    Am J Hematol; 2004 Jan; 75(1):22-33. PubMed ID: 14695629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
    Moon EY; Lerner A
    Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.
    Santini V; Gozzini A; Scappini B; Caporale R; Zoccolante A; Rigacci L; Gelardi E; Grossi A; Alterini R; Ferrini PR
    Haematologica; 1999 Oct; 84(10):897-904. PubMed ID: 10509037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
    Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C
    Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia.
    Goolsby C; Paniagua M; Tallman M; Gartenhaus RB
    Cytometry B Clin Cytom; 2005 Jan; 63(1):36-46. PubMed ID: 15624202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.
    Mackus WJ; Kater AP; Grummels A; Evers LM; Hooijbrink B; Kramer MH; Castro JE; Kipps TJ; van Lier RA; van Oers MH; Eldering E
    Leukemia; 2005 Mar; 19(3):427-34. PubMed ID: 15674362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.
    Eliopoulos AG; Kerr DJ; Herod J; Hodgkins L; Krajewski S; Reed JC; Young LS
    Oncogene; 1995 Oct; 11(7):1217-28. PubMed ID: 7478541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53.
    Christodoulopoulos G; Fotouhi N; Krajewski S; Reed JC; Alaoui-Jamali M; Panasci L
    Cancer Lett; 1997 Dec; 121(1):59-67. PubMed ID: 9459175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells.
    Bairey O; Vanichkin A; Shpilberg O
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e77-85. PubMed ID: 19208092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.